Galectin Therapeutics Inc. – Filings and Transcripts

NASDAQ: GALT
Share price (6/26/26): $4.99
Market cap (6/26/26): $329 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Shelf registration

Shelf registration

Registration of securities for employees

Registration of securities for employees

Shelf registration

Ownership Filter

Shlevin Harold H.

News Filter

Announces Positive Type C Meeting With the FDA for Belapectin in Patients With MASH Cirrhosis and Portal Hypertension

Reports March 31, 2026 Financial Results and Provides Business Update

Reports 2025 Financial Results and Provides Business Update

Strengthens Board of Directors With Appointment of Henry Brem, M.D

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Scanned paper annual report submission